A niche blog dedicated to the issues that arise when supplementary protection certificates (SPCs) extend patents beyond their normal life -- and to the respective positions of patent owners, investors, competitors and consumers. The blog also addresses wider issues that may be of interest or use to those involved in the extension of patent rights. You can email The SPC Blog here

Thursday 3 September 2009

ECJ Ruling on AHP Manufacturing v BIE

The judgement is out on ECJ case C-482/07 AHP Manufacturing BV v Bureau voor de Industriƫle Eigendom, also operating under the name Octrooicentrum Nederland, available here in French, German, Dutch and other languages, but unfortunately, not yet in English.

Here are the essentials questions and (distilled) answers:

1. Does Council Regulation (EEC) No 1768/92 of 18 June 1992 concerning the creation of a supplementary protection certificate for medicinal products, as subsequently amended, and more specifically Article 3(1)(c) thereof, preclude the grant of a certificate to the holder of a basic patent for a product for which, at the time of the submission of the application for a certificate, one or more certificates have already been granted to one or more holders of one or more other basic patents? - No

2. Does Regulation (EC) No 1610/96 of the European Parliament and of the Council of 23 July 1996 concerning the creation of a supplementary protection certificate for plant protection products, as subsequently amended, and more specifically recital 17 and the second sentence of Article 3(2) thereof, give rise to a different answer to Question 1? - No

Art. 3(1)(c) of Council Regulation 1768/92, in consideration of Art. 3(2) second sentence of Regulation 1610/96, should be interpreted such that it does not preclude the grant of a certificate to the holder of a basic patent for a product for which at the time of submission of the application, one or more certificates have already been granted to one or more holders of one or more basic patents. (see paragraph 43 of the decision)

3. When answering the previous questions, is it relevant whether the last application submitted, like the previous application or applications, is submitted within the period prescribed by Article 7(1) of Regulation (EEC) No 1768/92 or that prescribed by Article 7(2) of Regulation (EEC) No 1768/92? - No

4. When answering the previous questions, is it relevant whether the period of protection afforded by the grant of a certificate pursuant to Article 13 of Regulation (EEC) No 1768/92 expires at the same time as, or at a later time than, under one or more certificates already granted for the product concerned? - No

5. When answering the previous questions, is it relevant that Regulation (EEC) No 1768/92 does not specify the period within which the competent authority, as referred to in Article 9(1) of that Regulation, must process the application for a certificate and ultimately grant a certificate, as a result of which a difference in the speed with which the authorities concerned in the Member States process applications may lead to differences between them as to the possibility of a certificate being granted? - No

We'll provide more specifics on the reasoning in a later posting.

1 comment:

Trevor Cook said...

As I understand it from the French version, the Court takes the same view as the UK's IPO did in Chiron [2005] RPC 587 and rejected a purely literal interpretation of Article 3(c) of the Medicinal Products SPC Regulation that would preclude a subsequent applicant for an SPC from getting one because an earlier applicant had already got one, a situation not addressed by Article 3(2) of the Plant Protection Products SPC Regulation, the second sentence of which addresses the situation when two applications are pending together.